vs
Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
FULTON FINANCIAL CORP is the larger business by last-quarter revenue ($336.2M vs $209.6M, roughly 1.6× Varex Imaging Corp). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs 1.1%, a 27.1% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs 4.2%). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs 0.2%).
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
FULT vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $336.2M | $209.6M |
| Net Profit | $94.8M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | 28.2% | 1.1% |
| Revenue YoY | 4.2% | 4.9% |
| Net Profit YoY | 1.9% | 866.7% |
| EPS (diluted) | $0.55 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.2M | $209.6M | ||
| Q4 25 | $336.0M | $228.9M | ||
| Q3 25 | $334.6M | $203.0M | ||
| Q2 25 | $324.1M | $212.9M | ||
| Q1 25 | $318.4M | $199.8M | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $317.7M | $205.7M | ||
| Q2 24 | $334.7M | $209.1M |
| Q1 26 | $94.8M | $2.3M | ||
| Q4 25 | $99.0M | $12.2M | ||
| Q3 25 | $100.5M | $-89.1M | ||
| Q2 25 | $99.2M | $6.9M | ||
| Q1 25 | $93.0M | $-300.0K | ||
| Q4 24 | $68.6M | — | ||
| Q3 24 | $63.2M | $-51.1M | ||
| Q2 24 | $95.0M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 35.7% | 8.6% | ||
| Q3 25 | 38.2% | -39.8% | ||
| Q2 25 | 37.8% | 10.4% | ||
| Q1 25 | 36.1% | 5.6% | ||
| Q4 24 | 27.0% | — | ||
| Q3 24 | 25.1% | 5.3% | ||
| Q2 24 | 30.8% | 4.4% |
| Q1 26 | 28.2% | 1.1% | ||
| Q4 25 | 29.5% | 5.3% | ||
| Q3 25 | 30.0% | -43.9% | ||
| Q2 25 | 30.6% | 3.2% | ||
| Q1 25 | 29.2% | -0.2% | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 19.9% | -24.8% | ||
| Q2 24 | 28.4% | 0.7% |
| Q1 26 | $0.55 | $0.05 | ||
| Q4 25 | $0.53 | $0.29 | ||
| Q3 25 | $0.53 | $-2.15 | ||
| Q2 25 | $0.53 | $0.17 | ||
| Q1 25 | $0.49 | $-0.01 | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.33 | $-1.25 | ||
| Q2 24 | $0.52 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $3.5B | $476.9M |
| Total Assets | $32.2B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | — | $155.1M | ||
| Q3 25 | — | $152.6M | ||
| Q2 25 | — | $223.0M | ||
| Q1 25 | — | $212.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $200.5M | ||
| Q2 24 | — | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $3.5B | $476.9M | ||
| Q4 25 | $3.5B | $472.6M | ||
| Q3 25 | $3.4B | $455.3M | ||
| Q2 25 | $3.3B | $549.7M | ||
| Q1 25 | $3.3B | $540.2M | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.2B | $529.1M | ||
| Q2 24 | $3.1B | $581.2M |
| Q1 26 | $32.2B | $1.1B | ||
| Q4 25 | $32.1B | $1.1B | ||
| Q3 25 | $32.0B | $1.1B | ||
| Q2 25 | $32.0B | $1.4B | ||
| Q1 25 | $32.1B | $1.3B | ||
| Q4 24 | $32.1B | — | ||
| Q3 24 | $32.2B | $1.2B | ||
| Q2 24 | $31.8B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $304.5M | $7.9M | ||
| Q3 25 | $116.1M | $7.7M | ||
| Q2 25 | $91.7M | $16.6M | ||
| Q1 25 | $703.0K | $9.5M | ||
| Q4 24 | $416.6M | — | ||
| Q3 24 | $-22.0M | $25.9M | ||
| Q2 24 | $157.8M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | — | $9.8M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $19.9M | ||
| Q2 24 | — | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.9% | ||
| Q2 24 | — | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | 3.08× | 0.65× | ||
| Q3 25 | 1.16× | — | ||
| Q2 25 | 0.92× | 2.41× | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 6.07× | — | ||
| Q3 24 | -0.35× | — | ||
| Q2 24 | 1.66× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FULT
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
